Ginseng Peptide (GS-Peptide)
A bioactive peptide derived from ginseng that enhances immune response and reduces inflammatory markers through TLR signaling.
Research Status
Clinical trials
For research purposes only. Not approved for human use. Not medical advice.
Research Areas
Side Effects
Typically resolves within 2-4 hours. Apply ice if needed. Rotate injection sites to minimize recurrence. May be reduced by allowing solution to reach room temperature before injection.
May occur 2-6 hours after injection due to TLR4-mediated cytokine release. Usually self-resolving within 12-24 hours. Acetaminophen or ibuprofen may provide relief if needed.
Mild elevation in circulating lymphocytes (particularly NK cells) observed 4-24 hours post-injection. Reflects enhanced immune activation and is expected. Resolves within 48 hours.
Mild headache reported in <5% of trial participants. May be related to immune activation or dehydration. Ensure adequate hydration and consider timing of injection.
Transient fatigue lasting 4-12 hours reported in some users. Consistent with mild immune activation response. Typically improves with continued use as tolerance develops.
Rare reports in clinical trials. May be related to immune activation affecting gut-associated lymphoid tissue. Ensure injection is subcutaneous, not intramuscular or intravenous.
Rare but possible, particularly in individuals with ginseng sensitivity. Discontinue immediately and seek medical attention if rash spreads or breathing difficulty occurs. Have antihistamine available.
Can develop with repeated injections at the same site. Prevent by rotating injection sites systematically. If lipodystrophy develops, avoid injecting into affected areas for at least 3-6 months.
Dosing Reference
| Parameter | Value |
|---|---|
| Dose range | 200-400 mcg |
| Frequency | 1-2x daily |
| Timing | Morning and/or evening with food |
| Route | Subcutaneous |
Start at 200 mcg once daily and titrate upward based on immune markers and tolerability. For research purposes only. Dosing based on preliminary clinical trial data.
Research disclaimer
Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.
Reconstitution Guide
Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution
Do not shake the vial vigorously; gentle swirling prevents peptide degradation
Discard immediately if the solution appears cloudy, discolored, or contains visible particles
Use within 30 days of reconstitution when stored at 2–8°C
Do not freeze the reconstituted solution; freezing may denature the peptide
Use the PeptideVolt reconstitution calculator for your exact concentration
Molecular and Pharmacological Data
GS-Peptide is a bioactive peptide derived from Panax ginseng that activates toll-like receptor 4 (TLR4) signaling on immune cells, particularly dendritic cells and macrophages. This activation enhances the production of pro-inflammatory cytokines (TNF-α, IL-6) in a controlled manner and promotes natural killer (NK) cell differentiation and cytotoxic activity. The peptide also modulates the NF-κB and MAPK signaling pathways, leading to enhanced innate immune responses while simultaneously reducing chronic inflammatory markers through feedback regulation.
TLR4 Signaling Pathway
GS-Peptide binds to and activates TLR4 on the surface of innate immune cells (macrophages, dendritic cells), triggering MyD88-dependent and TRIF-dependent signaling cascades that lead to NF-κB and IRF3 activation, resulting in enhanced production of type I interferons and pro-inflammatory cytokines.
NK Cell Activation
The peptide enhances natural killer cell maturation and cytotoxic function through IL-15 and IL-12 signaling, increasing perforin and granzyme B expression and improving IFN-γ production for antiviral and anti-tumor immunity.
NF-κB and MAPK Signaling
GS-Peptide activates phosphorylation of p38 MAPK and ERK1/2, as well as IκB kinase (IKK) complex, leading to NF-κB nuclear translocation and enhanced expression of immune response genes while maintaining homeostatic feedback through negative regulators like SOCS proteins.
Antioxidant Response Element (ARE) Pathway
The peptide may activate Nrf2-mediated antioxidant response through mild oxidative stress signaling, upregulating expression of glutathione S-transferases and superoxide dismutase to support cellular antioxidant defenses.
- GS-Peptide acts as a TLR4 agonist, enhancing both innate and adaptive immune responses
- The peptide promotes NK cell differentiation and increases cytotoxic granule protein expression
- GS-Peptide modulates the balance between pro-inflammatory and anti-inflammatory signaling to support immune homeostasis
- The peptide is derived from ginseng saponin-associated peptide fractions and is distinct from whole ginseng extracts
- Clinical trials have demonstrated safety and immune marker improvements in healthy adult volunteers
Track your Ginseng Peptide (GS-Peptide) research
Free account. No credit card required.
Browse the Research Library
40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.
View all peptidesResearch Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Ginseng Peptide (GS-Peptide) is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.